Karma Capital is extremely bullish on the pharmaceutical and telecom sectors, seeing significant earnings growth over next two years in both sectors. Elevated inflation, higher interest rates for prolonged period, and global headwinds in form of unstable macros, geopolitical tensions, and recession fears could lead to growth slowing down this year, but over the long term, India’s structural growth prospects remain positive.
Subscribe To Our Free Newsletter |